General Information of Drug Formulation (ID: F02711)

Formulation Name
Brigatinib 30 mg tablet
Company
ARIAD Pharmaceuticals
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Brigatinib DM7W94S Anaplastic large cell lymphoma 2A90.A Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Lactose monohydrate E00393 104938 Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate E00208 11177 lubricant
Water E00035 962 Solvent